Phibro Animal Health (NASDAQ:PAHC) Downgraded to Buy Rating by StockNews.com

StockNews.com downgraded shares of Phibro Animal Health (NASDAQ:PAHCFree Report) from a strong-buy rating to a buy rating in a research report released on Friday.

Other research analysts have also issued reports about the company. Bank of America increased their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. Barclays increased their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective on the stock. Finally, Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $20.50.

Get Our Latest Research Report on PAHC

Phibro Animal Health Stock Performance

NASDAQ:PAHC opened at $21.05 on Friday. The company’s 50-day moving average is $23.29 and its two-hundred day moving average is $20.84. The firm has a market capitalization of $852.59 million, a price-to-earnings ratio of 48.95, a PEG ratio of 0.58 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were paid a $0.12 dividend. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.28%. Phibro Animal Health’s payout ratio is presently 111.63%.

Institutional Trading of Phibro Animal Health

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Sofinnova Investments Inc. acquired a new position in shares of Phibro Animal Health in the second quarter valued at approximately $3,975,000. American Century Companies Inc. boosted its position in Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after buying an additional 189,068 shares during the period. Jacobs Levy Equity Management Inc. grew its stake in shares of Phibro Animal Health by 116.6% in the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock worth $4,330,000 after acquiring an additional 103,491 shares in the last quarter. Dana Investment Advisors Inc. increased its position in shares of Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after acquiring an additional 75,546 shares during the period. Finally, Algert Global LLC raised its stake in shares of Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after acquiring an additional 59,850 shares in the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile

(Get Free Report)

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Further Reading

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.